Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Expression and Splice Variant Analysis of Human TCF4 Transcription Factor in Esophageal Cancer.

He G, Guan X, Chen X, Wang Y, Luo C, Zhang B.

J Cancer. 2015 Feb 15;6(4):333-41. doi: 10.7150/jca.10565. eCollection 2015.

2.

Acetylation of human TCF4 (TCF7L2) proteins attenuates inhibition by the HBP1 repressor and induces a conformational change in the TCF4::DNA complex.

Elfert S, Weise A, Bruser K, Biniossek ML, Jägle S, Senghaas N, Hecht A.

PLoS One. 2013 Apr 15;8(4):e61867. doi: 10.1371/journal.pone.0061867. Print 2013.

3.

Intrinsic properties of Tcf1 and Tcf4 splice variants determine cell-type-specific Wnt/β-catenin target gene expression.

Wallmen B, Schrempp M, Hecht A.

Nucleic Acids Res. 2012 Oct;40(19):9455-69. doi: 10.1093/nar/gks690. Epub 2012 Aug 2.

4.

Alternative splicing of Tcf7l2 transcripts generates protein variants with differential promoter-binding and transcriptional activation properties at Wnt/beta-catenin targets.

Weise A, Bruser K, Elfert S, Wallmen B, Wittel Y, Wöhrle S, Hecht A.

Nucleic Acids Res. 2010 Apr;38(6):1964-81. doi: 10.1093/nar/gkp1197. Epub 2009 Dec 30.

5.

Tissue-specific alternative splicing of TCF7L2.

Prokunina-Olsson L, Welch C, Hansson O, Adhikari N, Scott LJ, Usher N, Tong M, Sprau A, Swift A, Bonnycastle LL, Erdos MR, He Z, Saxena R, Harmon B, Kotova O, Hoffman EP, Altshuler D, Groop L, Boehnke M, Collins FS, Hall JL.

Hum Mol Genet. 2009 Oct 15;18(20):3795-804. doi: 10.1093/hmg/ddp321. Epub 2009 Jul 14.

Supplemental Content

Write to the Help Desk